Piñeiro Pérez Roi, Núñez Cuadros Esmeralda, Rodríguez Marrodán Belén, Escrig Fernández Raquel, Gil Lemus María Ángeles, Manzano Blanco Santiago, Calvo Cristina
Comité de Medicamentos de la Asociación Española de Pediatría (CM-AEP), Madrid España.
Comité de Medicamentos de la Asociación Española de Pediatría (CM-AEP), Madrid España.
An Pediatr (Engl Ed). 2021 Mar;94(3):188.e1-188.e9. doi: 10.1016/j.anpedi.2020.12.008. Epub 2021 Jan 26.
Since 2009, the use of off-label and unlicensed drugs has been regulated in Spain. In pediatrics, this exceptional use is more common than in other medical specialties. It varies from 10% to 90% of all prescriptions in children. This variability is due to differences in methodology, classification and sources of information used, and also to the different pediatrics subspecialties. In addition, the knowledge of several pediatricians on this issue is limited and more than half do not comply with the law, in many cases due to ignorance. However, the use of off-label and unlicensed drugs is legal and necessary. The Medicines Committee of the Spanish Association of Pediatrics (CM-AEP) considers that it is necessary to improve the existing information on medicines in the pediatric population. Therefore, the CM-AEP works out a document where suggestions and actions are proposed to achieve it, because children's health deserves it.
自2009年以来,西班牙已对标签外用药和未经许可药物的使用进行了规范。在儿科领域,这种特殊用药情况比其他医学专科更为常见。其在儿童所有处方中的占比从10%到90%不等。这种差异是由于所采用的方法、分类和信息来源不同,以及儿科不同亚专科之间的差异所致。此外,几位儿科医生在这个问题上的知识有限,超过半数的医生不遵守法律,在很多情况下是由于无知。然而,标签外用药和未经许可药物的使用是合法且必要的。西班牙儿科学会药品委员会(CM - AEP)认为有必要改善现有的关于儿科人群用药的信息。因此,CM - AEP制定了一份文件,其中提出了实现这一目标的建议和行动,因为儿童的健康值得如此。